Press Releases

Press Releases

Business Wire | February 08, 2018
Chief Executive Officer, President and Chairman, Kevin Hrusovsky, will be presenting at the LEERINK Partners 7th Annual Global Healthcare Summit. The presentation will take place on Thursday, February 15, at 10:00 a.m. EST in New York City.
Business Wire | January 04, 2018
Chief Executive Officer, President and Chairman, Kevin Hrusovsky, will present a company overview at the 36th Annual J.P. Morgan Healthcare Conference.
Business Wire | January 02, 2018
Ultra-Sensitive Biomarker Detection System is now available in a compact size with increased workflow flexibility
BusinessWire | December 11, 2017
Quanterix Corporation (NASDAQ:QTRX), a company with a next generation, ultra-sensitive digital platform that advances precision health, today announced the closing of its initial public offering of 4,916,480 shares of common stock at a public offering price of $15.00 per share, including 641,280…
Nasdaq | December 07, 2017
Quanterix Corporation (Nasdaq:QTRX), a company with a next generation, ultra-sensitive digital platform that advances precision health, will visit the Nasdaq MarketSite in Times Square.
Business Wire | December 06, 2017
Today Quanterix announced the pricing of its initial public offering of 4,275,200 shares of its common stock at a public offering price of $15.00 per share for aggregate gross proceeds of $64,128,000. In addition, Quanterix has granted the underwriters a 30-day option to purchase up to 641,280…
Business Wire | November 10, 2017
New technology unlocks ultra-sensitive biomarker detection with the potential to advance the diagnosis and treatment of neurological diseases
CHICAGO– December 18, 2014 Ten scientists are being honored as finalists for the 2015 SLAS Innovation Award, with the winner to be identified at the closing session of SLAS2015. The winner will receive a $10,000 cash prize along with having their name added to the prestigious list of previous…
LEXINGTON, MA – June 1, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that it is launching a series of conferences focused on the incredible potential and impact of…
LEXINGTON, MA – October 6, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced the publication of a collaborative whitepaper that addresses concussion management, science, policy…